Data Insights

Amitriptyline hydrochloride by AlgoTherapeutix for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval

Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Amitriptyline Hydrochloride in Chemotherapy Induced Peripheral Neuropathy

Data Insights

Amitriptyline hydrochloride by AlgoTherapeutix for Erythromelalgia: Likelihood of Approval

Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Amitriptyline Hydrochloride in Erythromelalgia

Data Insights

Amitriptyline hydrochloride by AlgoTherapeutix for Diabetic Peripheral Neuropathy: Likelihood of Approval

Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase I for Diabetic Peripheral Neuropathy. According to GlobalData,...

Data Insights

Amitriptyline hydrochloride by AlgoTherapeutix for Erythromelalgia: Likelihood of Approval

Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II...